Adamax
Trade-name identity TBD — no CID; Semax-context PMIDs only; ≠ Semax ≠ Selank; AdaMax ML collision.
Editorial review:Evidence snapshot
This drawer marks papers. It is not a plan, a dose, or a source. A paper is a bounded report. It is not a protocol. Grades name the object. They are not a safety rating.
Identity lock — To be confirmed. “Adamax” as sold/discussed in peptide communities is an unverified trade name, not a locked INN. Descriptions conflict across sources: some claim an adamantane-modified Semax analogue; others blur it with N-acetyl Semax amidate or other ACTH(4–10)-class derivatives. No PubChem CID is locked for Adamax in this pack. Do not invent a structure. Related but distinct locked objects: Semax (MEHFPGP) PubChem CID 9811102; N-acetyl Semax amidate CID 172638603; Selank CID 11765600 (≠ Adamax). PubMed hits for the string “Adamax” are often AdaMax optimizer machine-learning papers — wrong object. Never auto-merge Semax grades onto Adamax. Semax-context PMIDs carry explicit “Does not show: Adamax.” This drawer marks the identity problem and Semax-context papers only. It is not use advice.
Bottom line
Object-matched clinical or preclinical PubMed evidence for a verified “Adamax” chemical entity is essentially absent. Semax papers must not be graded as Adamax efficacy. Until structure is analytically confirmed for a named object, identity stays To be confirmed.
Papers
Adamax name collision — not peptide evidence
No Selected-sources PMID in this pack reports a controlled study of a chemically confirmed Adamax entity. Optimizer / “AdaMax” ML papers are excluded.
Different object — Semax context only (do not grade as Adamax)
PMID 29798983 — Gusev 2018
Tested: clinical efficacy narrative for Semax at different stages of ischemic stroke (Russian-language clinical context).
Does not show: Adamax efficacy; Semax ≠ Adamax.
PMID 32342318 — Panikratova 2020
Tested: functional connectomic approach studying Selank and Semax effects.
Does not show: Adamax identity or outcomes.
PMID 30225715 — Lebedeva 2018
Tested: effects of Semax on the brain default mode network.
Does not show: Adamax clinical cognition claims.
PMID 24661604 — Medvedeva 2014
Tested: Semax genome-wide transcriptional effects related to immune/vascular systems in rat focal ischemia.
Does not show: human Adamax trials.
PMID 28255762 — Medvedeva 2017
Tested: Semax regulation of immune-response gene expression during ischemic brain injury in rats.
Does not show: Adamax human neuroprotection.
PMID 27586814 — Magrì 2016
Tested: influence of N-terminus acetylation of Semax on copper(II)/zinc(II) coordination and biological properties (related analogue chemistry — still not confirmed Adamax).
Does not show: that N-acetyl Semax amidate or metal-coordination papers prove Adamax structure or efficacy.
PMID 40692165 — Liu 2025
Tested: Semax peptide targeting Oprm1 in a spinal-cord-injury recovery model (female mice).
Does not show: Adamax interchangeability.
What is not established
A verified PubChem structure/CID for Adamax. That a product labeled “Adamax” equals Semax, N-acetyl Semax amidate, or any adamantane conjugate. Any human clinical efficacy for Adamax. That Semax stroke/cognition papers transfer to unlabeled Adamax vials. This drawer does not provide use advice, schedules, or sourcing.
Selected sources
29798983 32342318 30225715 24661604 28255762 27586814 40692165
Reported experiences
Reported topics are not established benefits.Risks and unknowns
Compare experiences with care.
Join the discussion
Verified members can contribute to compound conversations.